18Jan 2022
Changes in the expression of a junctional protein are associated with mutational status of BRAF and survival in melanoma

Changes in the expression of a junctional protein are associated with mutational status of BRAF and survival in melanoma

Melanoma is a serious form of skin cancer that arises when pigment cells in the skin (melanocytes) become malignant (cancerous). During their lifetime melanoma develops in about 1 in 40 people in the UK. Melanoma can spread to other parts of the body (i.e. ‘metastasize’), and metastatic melanoma is one of the deadliest cancers. Several mutations (faults in genetic code) have been found in metastatic melanoma including the BRAF mutation. The development of a type of treatment using inhibitors of mutated BRAF have signaled a positive step in the fight against melanoma, with encouraging response rates. However, due to the development of resistance to such therapies, the search for additional combination treatments and new biomarkers to help predict which patients will respond to different treatments remains a challenge...

  • #dermatology

Like

Save

Share